FOLLOW US
For Professionals » Research Updates » Hyperthyroidism

Hyperthyroidism Research Updates

For Medical Professionals

TED, Teprotumumab and Hearing Loss: What You Need to Know Now
Hyperthyroidism May Raise Individual Risk of Dementia
No Excess Cancer Risk from Radioactive Iodine Treatment in Hyperthyroidism
Patients who choose radioactive iodine therapy to treat hyperthyroidism and Graves disease are not at increased risk for developing cancer, say experts.
Tepezza—A Breakthrough, Non-Surgical Treatment for Thyroid Eye Disease
Factors Predicting Relapse of Graves’ Disease
ATA Guidelines Updated for Managing Hyperthyroidism
Altered Brain Functioning May Explain Cognitive Difficulties and Depression After Thyroid Hormone Withdrawal Following Thyroidectomy
Patients with acute hypothyroidism following total thyroidectomy have increased local brain functional connectivity, which correlates with poorer mental quality of life and depression.
Subclinical Hyperthyroidism Increases Risk of Hip and Other Fractures
Subclinical hyperthyroidism was associated with an increased risk of hip fracture and other fractures in an observational study involving data from more than 70,000 participants.
Hyperthyroidism, T4 Levels Linked to Hypertension in Pregnancy
Hyperthyroidism and high-normal free T4 levels in pregnancy are associated with an increased risk for pregnancy-induced hypertension and preeclampsia, according to findings from a population-based cohort study. The study was published online ahead of print in the Journal of Clinical Endocrinology and Metabolism.
Levoxyl Returns to the Market
After being off the marked for over a year, the branded medication Levoxyl (levothyroxine sodium) is expected to be available in pharmacies on approximately March 3, 2014, according to a statement released by Pfizer. The medication is approved to treat hypothyroidism and various types of euthyroid goiters.
close X
SHOW MAIN MENU
SHOW SUB MENU